FeaturesSignalPricingFounders
Log inGet started free
B&

Burrill & Company

Private EquityActive

Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

San Francisco, United StatesFounded 2013b-llc.com/
87
Investments
10
Exits
$1.4B
AUM
11.5%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Burrill & Company.

Get started free

Investment Thesis & Strategy

Burrill & Company invests in various stages of life sciences, biotechnology, and healthcare companies, leveraging its expertise to drive growth and innovation within these sectors.

Notable Exits

CompanyTypeYearValue / Acquirer
DendreonAcquisition2015$480M
Ambit BiosciencesAcquisition2014$410M
XencorIPO2013
Onyx PharmaceuticalsAcquisition2013$10.4B
Theravance BiopharmaIPO2013
GenentechAcquisition2009$46.8B
MedImmuneAcquisition2007$15.6B
Sirna TherapeuticsAcquisition2006$550M
Ligand PharmaceuticalsIPO1992
Gilead SciencesIPO1992

Frequently Asked Questions

Burrill & Company focuses on Series B, Series C+ stage investments.

Related Investors